The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial.

Trial Profile

The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Benidipine (Primary) ; Angiotensin receptor antagonists; Beta-adrenergic receptor antagonists; Thiazide diuretics
  • Indications Cardiovascular disorders; Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COPE
  • Most Recent Events

    • 21 Feb 2012 Last checked against ClinicalTrials.gov record.
    • 21 Feb 2012 Actual end date changed from Sep 2010 to Nov 2010 as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Official title amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top